F 0585
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Honor the resident's right to voice grievances without discrimination or reprisal and the facility must
establish a grievance policy and make prompt efforts to resolve grievances.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on a
review of select facility policies, clinical records, grievances filed with the facility, and staff interviews, it was
determined that the facility failed to make prompt and adequate efforts to resolve a resident grievance in
accordance with facility policy, for one of ten residents sampled (Resident 1).Findings Include: A review of
facility policy entitled Grievance Process Procedure last reviewed by the facility on May 2, 2025, revealed it
is the policy of the facility to make prompt efforts to resolve resident grievances to the satisfaction of the
resident and or resident representative. The policy indicated a resolution of the concern is desired within
five (5) working days from the date the concern was filed. The policy indicated routine follow up on
concerns that are outstanding will be completed through the morning process meeting. The policy further
identified the grievance official as the Nursing Home administrator (NHA). A grievance is defined as a
formal or informal complaint or concern expressed by a resident or resident representative regarding care,
services, or conditions at the facility. A review of Resident 1's clinical record revealed the resident was
admitted to the facility on [DATE], at 5:20 PM, with diagnoses to include frequent falls and chronic pain
syndrome (a condition characterized by persistent pain lasting longer than three months) and was
discharged from the facility on November 15, 2025. A review of a Grievance/Concern Form filed by
Resident 1 on November 7, 2025, revealed the resident reported that he did not receive his prescribed
oxycodone 10 mg (a narcotic analgesic medication prescribed for the treatment of moderate to severe pain
and requires timely administration as ordered to manage pain) upon admission to the facility. Further review
of the grievance form indicated the grievance was assigned to the Director of Nursing and Unit Manager for
follow up. A review of Resident 1's Medication Administration Record and progress notes revealed the
resident's ordered narcotic pain medication was not administered until November 8, 2025, at 4:56 PM,
following admission to the facility. Further review of the grievance documentation revealed social services
met with Resident 1 to discuss the concern on November 10, 2025. Review of the grievance resolution
section indicated the grievance was closed with the notation that the resident was discharged prior to
resolution. The grievance form was signed by the Nursing Home Administrator, identified by policy as the
grievance official. Review of the timeline revealed the resident remained in the facility for eight days
following the filing of the grievance, exceeding the facility's stated five working day timeframe for grievance
resolution. There was no documented evidence that the facility timely evaluated the resident's grievance
regarding the failure to receive prescribed narcotic pain medication upon admission. There was no
documented evidence of attempts to resolve the grievance within five working days, as required by facility
policy, nor was there documentation of corrective action, findings, or communication of a resolution to the
resident prior to discharge. An interview with the Nursing Home Administrator on December 30, 2025, at
1:00 PM, revealed that the Director of Nursing printed the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
395691
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395691
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Riverstreet Manor
440 North River Street
Wilkes-Barre, PA 18702
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0585
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
resident's Medication Administration Record in response to the grievance; however, the Nursing Home
Administrator confirmed no further action was taken to resolve the grievance. An interview with the Nursing
Home Administrator on December 30, 2025, at 1:40 PM, reviewed the above findings and confirmed the
facility did not resolve Resident 1's grievance regarding the receipt of prescribed oxycodone prior to
discharge. 28 Pa. Code 201.18 (e)(1) Management. 28 Pa Code 211.10 (c) Resident care policies.28 Pa.
Code 211.12 (c)(d)(3)(5) Nursing services
Event ID:
Facility ID:
395691
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395691
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Riverstreet Manor
440 North River Street
Wilkes-Barre, PA 18702
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
review of resident clinical records, select facility policy, and staff interview it was revealed that the facility
failed to assure that one of 10 residents reviewed were free of significant medication errors. (Resident
1)Findings include: A review of a facility policy, entitled Reconciliation of Medications on Admission last
reviewed by the facility on May 2, 2025, defined the medication reconciliation process as the process of
comparing pre-discharge medications to post-discharge medications by creating an accurate list of both
prescriptions. The policy further detailed the steps in completing a medication reconciliation which included
gathering the information needed to reconcile the medication list by using the approved medication
reconciliation form, the discharge summary from the referring facility, the admission order sheet, and all
prescription and supplement information obtained from the resident/family during the medication history.
The policy further explained that the medication reconciliation process is used to ensure that all
medications, routes, and dosages on the list are appropriate for the resident and his/her condition. The
policy explained that medication reconciliation helps to ensure the medications, routes and dosages have
been accurately communicated to the Attending Physician and care team. The steps portion of the policy
directed staff to ask the resident or responsible party to list all physician and pharmacies from which he or
she obtained medications. The policy revealed that if there was a discrepancy between documentation, the
staff member was to contact the nurse from the referring facility, contact the physician from the referring
facility, discuss the findings with the resident/family, contact the residents outside provider and pharmacies
for an accurate list of current medications. The policy then directed staff to document any discrepancy on
the medication reconciliation form, what actions were taken by the nurse to resolve the discrepancy, and
document whether the discrepancy was resolved or not. A review of the clinical record revealed that
Resident 1 was admitted to the facility on [DATE], with diagnosis to include hypertension (a condition blood
pushes too forcefully against artery walls) and hypothyroidism (a condition when the thyroid gland doesn't
make enough thyroid hormone). A review of Resident 1's clinical record revealed that upon admission,
records were obtained from the referring facility which included a current medication list dated November 3,
2025. The list included the following medications:Sennoside 8.6mg-1 tablet by mouth twice a day for
constipation.Pantoprazole 40mg- 1 tablet by mouth daily for acid reflux.Tiotropium 2.5mcg- 2 inhalations by
mouth daily for breathing.Bacitracin 500units/gm ointment- apply moderate amount topically twice a day for
skin infection.Aspirin 81mg- take one tablet by mouth daily every day for heart health.Oxybutynin 5mg- take
one tablet by moth twice a day for overactive bladder.Levothyroxine 175mg- take one tablet by mouth every
day at 6am for thyroid hormone replacement.Fluticasone/Salmeterol- inhale 1 puff by mouth twice a day for
breathing. Semaglutide 0.25mg/0.375ml- Inject 0.5mg subcutaneously once weekly for diabetes.Hydrophilic
cream- apply small amount topically every day for dry skin.Oxycodone 10mg- Take one tablet every 4 hours
for pain.Losartan 50mg- Take one half tablet by mouth daily for blood pressure.Gabapentin 300mg- take
one capsule by mouth three times a day for pain.Magnesium oxide 400mg- take one tablet by mouth daily
for low magnesium.Famotidine 20mg- take one tablet by mouth twice daily.Finasteride 5mg- take one tablet
by mouth daily for prostate.Apixaban 5mg- take 1 tablet every 12 hours for atrial fibrillation (an irregular
heartbeat).Acetaminophen 325mg- take one tablet every 4 hours as needed for pain.Allopurinol 300mgtake one tablet by mouth daily for gout (an inflammatory disease). Ferrous Gluconate 324mg- take one
tablet every other day for iron replacement.Furosemide 40mg- take one tablet by mouth daily for swelling
and blood pressure.Tamsulosin 0.4mg- take one capsule by mouth twice a day for enlarged prostate (male
reproductive gland).Further
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395691
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395691
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Riverstreet Manor
440 North River Street
Wilkes-Barre, PA 18702
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
review of Resident 1's clinical record revealed the facility failed to ensure an accurate and complete
medication reconciliation was completed upon admission, resulting in the resident being placed on
medications that had been previously discontinued.A review of Resident 1's clinical record revealed that
upon admission, the resident was placed on the following medications that were not included on the current
medication list provided by the referring facility:Methimazole 10 mg, administer one half tablet by mouth
every Saturday and Sunday for hyperthyroidism (a condition in which the thyroid gland produces excessive
thyroid hormone), despite referring facility documentation indicating the resident was being treated with
levothyroxine 175 mcg for hypothyroidism (a condition in which the thyroid gland does not produce enough
thyroid hormone), representing conflicting thyroid therapies.Simvastatin 40 mg, one tablet by mouth in the
evening for high cholesterol, despite the medication not being included on the current medication list from
the referring facility.Lisinopril 20 mg, one tablet by mouth every morning for hypertension, despite the most
recent medication list documenting the resident was being treated with losartan for blood pressure
control.A review of the referring facility's clinical documentation revealed that lisinopril 20 mg was
discontinued on May 22, 2024, due to an episode of hyperkalemia (a condition in which potassium levels in
the blood are abnormally elevated, which can interfere with heart rhythm and muscle function and may
result in life-threatening complications). The referring documentation further confirmed that methimazole
and simvastatin were also discontinued at that time. A review of Resident 1's progress notes revealed a
nursing entry dated November 11, 2025, at 4:38 PM, documenting that the provider ordered laboratory
testing to be completed on November 12, 2025, and directed that lisinopril be discontinued. A review of
Resident 1's laboratory results dated [DATE], at 7:35 AM, revealed the resident's potassium level was
elevated at 5.2 mmol/L (normal range 3.5-5.1mmol/L).A review of Resident 1's progress notes revealed a
note dated November 12, 2025, at 12:21 PM, documenting that the provider was notified of the elevated
potassium level, reviewed the laboratory results, and issued a new order to administer Kayexalate, a
medication used to treat hyperkalemia by lowering potassium levels in the blood. An interview with the
Nursing Home Administrator conducted on December 30, 2025, at 1:00 PM, revealed that a medication list
dated May 22, 2024, was utilized during the admission medication reconciliation process, despite the
referring facility's clinical record containing an updated medication list dated November 3, 2025. The
Nursing Home Administrator confirmed the facility failed to reconcile medications in accordance with facility
policy, resulting in Resident 1 receiving multiple discontinued medications, including lisinopril, which
contributed to another episode of hyperkalemia. An additional interview with the Nursing Home
Administrator on December 30, 2025, at 1:40 PM, confirmed the above findings and acknowledged that the
medication reconciliation process was not completed as required by facility policy, resulting in the facility's
failure to ensure the resident was free from a medication error. 28 Pa. Code 211.10 (c) Resident Care
Policies 28 Pa. Code 211.12 (d)(5) Nursing Services. 28 Pa. Code 211.9 (a)(1)(d) Pharmacy Services.
Event ID:
Facility ID:
395691
If continuation sheet
Page 4 of 4